Impact of Anti-PD-1 and Anti-CTLA-4 on the Human Immunodeficiency Virus (HIV) Reservoir in People Living With HIV With Cancer on Antiretroviral Therapy: The AIDS Malignancy Consortium 095 Study.
Saved in:
| Title: | Impact of Anti-PD-1 and Anti-CTLA-4 on the Human Immunodeficiency Virus (HIV) Reservoir in People Living With HIV With Cancer on Antiretroviral Therapy: The AIDS Malignancy Consortium 095 Study. |
|---|---|
| Authors: | Rasmussen TA; The Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital, Melbourne, Australia., Rajdev L; Department of Haematology and Oncology, Lennox Hill Hospital, New York, New York, USA., Rhodes A; The Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital, Melbourne, Australia., Dantanarayana A; The Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital, Melbourne, Australia., Tennakoon S; The Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital, Melbourne, Australia., Chea S; The Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital, Melbourne, Australia., Spelman T; The Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital, Melbourne, Australia., Lensing S; Department of Biostatistics, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA., Rutishauser R; Department of Medicine, University of California, San Francisco, San Francisco, California, USA., Bakkour S; Vitalant Research Institute and Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California, USA., Busch M; Vitalant Research Institute and Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California, USA., Siliciano JD; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Siliciano RF; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Einstein MH; Department of Obstetrics, Gynecology, and Reproductive Health, Rutgers New Jersey Medical School, Newark, New Jersey, USA., Dittmer DP; Lineberger Comprehensive Cancer Center and Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Chiao E; Baylor College of Medicine, Houston, Texas, USA., Deeks SG; Department of Medicine, University of California, San Francisco, San Francisco, California, USA., Durand C; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Lewin SR; The Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital, Melbourne, Australia.; Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, Australia.; Victorian Infectious Diseases Service, The Royal Melbourne Hospital, Melbourne, Australia. |
| Source: | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Oct 05; Vol. 73 (7), pp. e1973-e1981. |
| Publication Type: | Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
